Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Antidiuretic hormone and serum osmolarity physiology and related outcomes: What is old, what is new and what is unknown?

Kanbay M, Yilmaz S, Dincer N, Ortiz A, Sag AA, Covic A, Sánchez-Lozada LG, Lanaspa MA, Cherney DZI, Johnson RJ, Afsar B.

J Clin Endocrinol Metab. 2019 Jul 31. pii: jc.2019-01049. doi: 10.1210/jc.2019-01049. [Epub ahead of print]

PMID:
31365096
2.

Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.

Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Kucuksumer ZS, Ortiz A, Covic A, Kuwabara M, Cherney DZI, van Raalte DH, de Zeeuw D.

Diabetes Obes Metab. 2019 Jul 12. doi: 10.1111/dom.13831. [Epub ahead of print] Review.

PMID:
31297976
3.

Intravenous Iron and Maintenance Hemodialysis.

Afsar B, Elsurer Afsar R, Kanbay M.

N Engl J Med. 2019 Jun 13;380(24):e46. doi: 10.1056/NEJMc1902945. No abstract available.

PMID:
31189053
4.

Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy.

Busuioc RM, Covic A, Kanbay M, Banach M, Burlacu A, Mircescu G.

Nephrol Dial Transplant. 2019 Jun 3. pii: gfz108. doi: 10.1093/ndt/gfz108. [Epub ahead of print]

PMID:
31157893
5.

The role of uric acid in mineral bone disorders in chronic kidney disease.

Afsar B, Sag AA, Oztosun C, Kuwabara M, Cozzolino M, Covic A, Kanbay M.

J Nephrol. 2019 Apr 27. doi: 10.1007/s40620-019-00615-0. [Epub ahead of print] Review.

PMID:
31030381
6.

Air pollution and kidney disease: review of current evidence.

Afsar B, Elsurer Afsar R, Kanbay A, Covic A, Ortiz A, Kanbay M.

Clin Kidney J. 2019 Feb;12(1):19-32. doi: 10.1093/ckj/sfy111. Epub 2018 Nov 12.

7.

Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin.

Ureche C, Tapoi L, Volovat S, Voroneanu L, Kanbay M, Covic A.

J Hum Hypertens. 2019 Jun;33(6):429-435. doi: 10.1038/s41371-019-0163-5. Epub 2019 Jan 18. Review.

PMID:
30659278
8.

Potential Dangers of Serum Urate-Lowering Therapy.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Kanbay M, Ortiz A.

Am J Med. 2019 Apr;132(4):457-467. doi: 10.1016/j.amjmed.2018.12.010. Epub 2019 Jan 3. Review.

PMID:
30611833
9.

Multilayered Interplay Between Fructose and Salt in Development of Hypertension.

Eren OC, Ortiz A, Afsar B, Covic A, Kuwabara M, Lanaspa MA, Johnson RJ, Kanbay M.

Hypertension. 2019 Feb;73(2):265-272. doi: 10.1161/HYPERTENSIONAHA.118.12150. No abstract available.

PMID:
30595116
10.

Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injury.

Dagel T, Misirlioglu S, Tanju S, Afsar B, Selcukbiricik F, Erus S, Vatansever D, Balik E, Taskiran C, Dilege S, Molinas Mandel N, Bugra D, Yalti T, Kanbay M.

J BUON. 2018 Sep-Oct;23(5):1528-1533.

11.

Effect of Social, regional, and education status and season on blood pressure.

Yerlikaya A, Afsar B, Kanbay M.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):217-219. doi: 10.1111/jch.13461. Epub 2018 Dec 20. No abstract available.

12.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
13.

The effect of chronic kidney disease on lipid metabolism.

Dincer N, Dagel T, Afsar B, Covic A, Ortiz A, Kanbay M.

Int Urol Nephrol. 2019 Feb;51(2):265-277. doi: 10.1007/s11255-018-2047-y. Epub 2018 Dec 5. Review.

PMID:
30519980
14.

Fasting blood glucose is predictive of hypertension in a general Japanese population.

Kuwabara M, Chintaluru Y, Kanbay M, Niwa K, Hisatome I, Andres-Hernando A, Roncal-Jimenez C, Ohno M, Johnson RJ, Lanaspa MA.

J Hypertens. 2019 Jan;37(1):167-174. doi: 10.1097/HJH.0000000000001895.

PMID:
30507865
15.

Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.

Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M.

Hypertens Res. 2019 Feb;42(2):123-140. doi: 10.1038/s41440-018-0144-z. Epub 2018 Nov 30. Review.

PMID:
30504819
16.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
17.

Arterial stiffness mediates the effect of salt intake on systolic blood pressure.

Siriopol D, Covic A, Iliescu R, Kanbay M, Tautu O, Radulescu L, Mitu O, Salaru D, Dorobantu M.

J Clin Hypertens (Greenwich). 2018 Nov;20(11):1587-1594. doi: 10.1111/jch.13399. Epub 2018 Oct 7.

18.

Acute effects of salt on blood pressure are mediated by serum osmolality.

Kanbay M, Aslan G, Afsar B, Dagel T, Siriopol D, Kuwabara M, Incir S, Camkiran V, Rodriguez-Iturbe B, Lanaspa MA, Covic A, Johnson RJ.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1447-1454. doi: 10.1111/jch.13374. Epub 2018 Sep 19.

19.

Ascorbic acid: a promising agent in chronic kidney disease?

Karahan S, Afsar B, Kanbay M.

Clin Kidney J. 2018 Aug;11(4):530-531. doi: 10.1093/ckj/sfy044. Epub 2018 Jun 26.

20.

Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver.

Jensen T, Niwa K, Hisatome I, Kanbay M, Andres-Hernando A, Roncal-Jimenez CA, Sato Y, Garcia G, Ohno M, Lanaspa MA, Johnson RJ, Kuwabara M.

Sci Rep. 2018 Aug 6;8(1):11735. doi: 10.1038/s41598-018-30267-2.

21.

The Effects of Bariatric Surgery on Renal Outcomes: a Systematic Review and Meta-analysis.

Bilha SC, Nistor I, Nedelcu A, Kanbay M, Scripcariu V, Timofte D, Siriopol D, Covic A.

Obes Surg. 2018 Dec;28(12):3815-3833. doi: 10.1007/s11695-018-3416-4.

PMID:
30054877
22.

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Toxins (Basel). 2018 Jul 19;10(7). pii: E300. doi: 10.3390/toxins10070300. Review.

23.

Capillary rarefaction from the kidney point of view.

Afsar B, Afsar RE, Dagel T, Kaya E, Erus S, Ortiz A, Covic A, Kanbay M.

Clin Kidney J. 2018 Jun;11(3):295-301. doi: 10.1093/ckj/sfx133. Epub 2017 Nov 28.

24.

Uric Acid and Hypertension Because of Arterial Stiffness.

Kuwabara M, Kanbay M, Hisatome I.

Hypertension. 2018 Sep;72(3):582-584. doi: 10.1161/HYPERTENSIONAHA.118.11496. No abstract available.

PMID:
29987106
25.

The Future of IL-1 Targeting in Kidney Disease.

Afsar B, Covic A, Ortiz A, Afsar RE, Kanbay M.

Drugs. 2018 Jul;78(11):1073-1083. doi: 10.1007/s40265-018-0942-2. Review.

PMID:
29968152
26.

Is relative overhydration measurement by bioimpedance spectroscopy useful in reducing morbidity and mortality in chronic kidney disease?

Karaaslan DC, Afsar B, Kanbay M.

Clin Kidney J. 2018 Jun;11(3):370-371. doi: 10.1093/ckj/sfy021. Epub 2018 Apr 2.

27.

Can Incidental Vascular Calcifications at Mammography be Used as a Screening Biomarker for Heart and Kidney Disease?

Erbil D, Onal EM, Demirel C, Sag AA, Dagel T, Afsar B, Covic A, Kanbay M.

Angiology. 2018 Jan 1:3319718779322. doi: 10.1177/0003319718779322. [Epub ahead of print]

PMID:
29886750
28.

Salt Intake and Immunity.

Afsar B, Kuwabara M, Ortiz A, Yerlikaya A, Siriopol D, Covic A, Rodriguez-Iturbe B, Johnson RJ, Kanbay M.

Hypertension. 2018 Jul;72(1):19-23. doi: 10.1161/HYPERTENSIONAHA.118.11128. Epub 2018 May 14. Review. No abstract available.

PMID:
29760151
29.

The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A, Vaziri ND.

Int Urol Nephrol. 2018 Aug;50(8):1453-1466. doi: 10.1007/s11255-018-1873-2. Epub 2018 May 4. Review.

PMID:
29728993
30.

Disorders of Lipid Metabolism in Chronic Kidney Disease.

Bulbul MC, Dagel T, Afsar B, Ulusu NN, Kuwabara M, Covic A, Kanbay M.

Blood Purif. 2018;46(2):144-152. doi: 10.1159/000488816. Epub 2018 Apr 27. Review.

31.

Effects of Volume Overload and Current Techniques for the Assessment of Fluid Status in Patients with Renal Disease.

Ekinci C, Karabork M, Siriopol D, Dincer N, Covic A, Kanbay M.

Blood Purif. 2018;46(1):34-47. doi: 10.1159/000487702. Epub 2018 Apr 12. Review.

32.

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

Afsar B, Kanbay M.

N Engl J Med. 2018 Apr 5;378(14):1362. doi: 10.1056/NEJMc1802033. No abstract available.

PMID:
29619814
33.

The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review.

Afsar B, Siriopol D, Aslan G, Eren OC, Dagel T, Kilic U, Kanbay A, Burlacu A, Covic A, Kanbay M.

Int Urol Nephrol. 2018 May;50(5):885-904. doi: 10.1007/s11255-018-1790-4. Epub 2018 Jan 17. Review.

PMID:
29344881
34.

Renal artery intervention utilizing carbon dioxide angiography.

Sag AA, Afsar B, Kanbay M.

Clin Kidney J. 2017 Dec;10(6):776-777. doi: 10.1093/ckj/sfx095. Epub 2017 Oct 9.

35.

Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal.

Burlacu A, Genovesi S, Goldsmith D, Rossignol P, Ortiz A, Kalra PA, Małyszko J, Banach M, Kanbay M, Covic A.

Pharmacol Res. 2018 Mar;129:535-543. doi: 10.1016/j.phrs.2017.12.004. Epub 2017 Dec 5. Review.

PMID:
29208494
36.

Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.

Voroneanu L, Siriopol D, Apetrii M, Hogas S, Onofriescu M, Nistor I, Kanbay M, Dumea R, Cusai S, Cianga P, Constantinescu D, Covic A.

Angiology. 2018 May;69(5):449-455. doi: 10.1177/0003319717733371. Epub 2017 Oct 3.

PMID:
28974104
37.

Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis.

Covic A, Ciumanghel AI, Siriopol D, Kanbay M, Dumea R, Gavrilovici C, Nistor I.

Int Urol Nephrol. 2017 Dec;49(12):2231-2245. doi: 10.1007/s11255-017-1698-4. Epub 2017 Sep 30. Review.

PMID:
28965299
38.

Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial.

Voroneanu L, Siriopol D, Dumea R, Badarau S, Kanbay M, Afsar B, Gavrilovici C, Covic A.

Int Urol Nephrol. 2017 Dec;49(12):2195-2204. doi: 10.1007/s11255-017-1697-5. Epub 2017 Sep 25.

PMID:
28948420
39.

Should we take renal denervation with a grain of salt?

Afsar B, Sag AA, Kanbay M.

J Clin Hypertens (Greenwich). 2017 Nov;19(11):1134-1136. doi: 10.1111/jch.13069. Epub 2017 Sep 24. No abstract available.

40.

Iron in kidney and heart failure: from theory to practice.

Yerlikaya A, Bulbul MC, Afsar B, Dagel T, Aslan G, Voroneanu L, Siriopol D, Covic A, Kanbay M.

Int Urol Nephrol. 2018 Mar;50(3):481-493. doi: 10.1007/s11255-017-1708-6. Epub 2017 Sep 22. Review.

PMID:
28940112
41.

Revisiting angioplasty for renovascular hypertension.

Sag AA, Kanbay M.

Clin Kidney J. 2017 Aug;10(4):494-495. doi: 10.1093/ckj/sfx065. Epub 2017 Jul 29.

42.

Serum uric acid and acute kidney injury: A mini review.

Hahn K, Kanbay M, Lanaspa MA, Johnson RJ, Ejaz AA.

J Adv Res. 2017 Sep;8(5):529-536. doi: 10.1016/j.jare.2016.09.006. Epub 2016 Sep 24. Review.

43.

Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.

Hogas S, Bilha SC, Branisteanu D, Hogas M, Gaipov A, Kanbay M, Covic A.

Arch Med Sci. 2017 Jun;13(4):897-913. doi: 10.5114/aoms.2016.58664. Epub 2016 Mar 22.

44.

Cardiovascular Effects of Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Meta-Analysis.

Aslan G, Afsar B, Siriopol D, Kanbay A, Sal O, Benli C, Okcuoglu J, Covic A, Kanbay M.

Angiology. 2018 Mar;69(3):195-204. doi: 10.1177/0003319717709175. Epub 2017 May 16.

PMID:
28506075
45.

Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Afsar B, Rossignol P, van Heerebeek L, Paulus WJ, Damman K, Heymans S, van Empel V, Sag A, Maisel A, Kanbay M.

Heart Fail Rev. 2017 Nov;22(6):765-773. doi: 10.1007/s10741-017-9619-2. Review.

PMID:
28497230
46.

Reply to: Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?

Sahan DO, Kanbay M.

Angiology. 2017 Aug;68(7):650. doi: 10.1177/0003319717708101. Epub 2017 May 10. No abstract available.

PMID:
28488888
47.

Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension.

Onal EM, Sag AA, Sal O, Yerlikaya A, Afsar B, Kanbay M.

Clin Exp Hypertens. 2017;39(3):197-209. doi: 10.1080/10641963.2016.1246565. Review.

PMID:
28448184
48.

The systemic nature of CKD.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA).

Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. Review.

PMID:
28435157
49.

Erratum to: Dietary and commercialized fructose: Sweet or sour?

Yerlikaya A, Dagel T, King C, Kuwabara M, Lanaspa MA, Andres-Hernando A, Covic A, Manitius J, Sag AA, Kanbay M.

Int Urol Nephrol. 2017 Sep;49(9):1699. doi: 10.1007/s11255-017-1579-x. No abstract available.

PMID:
28382575
50.

The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients.

Burlacu A, Genovesi S, Ortiz A, Kanbay M, Rossignol P, Banach M, Malyszko J, Goldsmith D, Covic A.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1967-1976. doi: 10.1093/ndt/gfx041. Review.

PMID:
28371905

Supplemental Content

Loading ...
Support Center